Standout Papers

Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma 2017 2026 2020 2023 849
  1. Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma (2017)
    Jeffrey S. Weber, F. Stephen Hodi et al. Journal of Clinical Oncology

Citation Impact

3 by Nobel laureates 9 from Science/Nature 65 standout
Sub-graph 1 of 22

Citing Papers

Theranostic Fluorescent Probes
2024 Standout
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
2023 Standout
2 intermediate papers

Works of Hewei Li being referenced

Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma
2017 Standout

Author Peers

Author Molecular Biology Oncology Pharmacology PRM Last Decade Papers Cites
Hewei Li 405 1061 112 328 35 1.6k
Yueshan Fan 84 14 5 17 15 347
Marlène Jobard 382 2 8 1 14 594
Divya Krishnamoorthy 47 11 156 2 11 299
Linan Ma 469 199 25 113 14 1.3k
Shui Ying Xiang 2 25 512

All Works

Loading papers...

Rankless by CCL
2026